Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Actual shortage | 2025-01-09 | 2025-05-08 | 247316 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Actual shortage | 2025-02-20 | 2025-05-02 | 250900 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2023-06-20 | 2023-06-27 | 195861 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-10-17 | 2020-05-21 | 96724 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2019-08-06 | 86933 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2020-05-01 | 86936 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-12-15 | 2023-06-09 | 178527 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2023-06-26 | 2023-07-21 | 196448 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176761 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176764 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2025-02-13 | 2025-02-28 | 250387 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2023-12-14 | 2024-02-15 | 213365 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132663 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110770 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110773 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2020-04-03 | 2020-05-08 | 110767 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111854 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-12-17 | 2021-12-23 | 151459 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-01-20 | 2022-04-01 | 153183 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| RATIO-LENOLTEC NO 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |